The clarification has been attached herewith in pursuant to additional details required for the corporate announcement filed under Regulation 30
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Choksi Laboratories Ltd submitted a clarification to BSE responding to queries about a CFO change disclosure. The company confirmed that Mr. Vyangesh Choksi resigned as CFO on May 5, 2026, with the resignation effective and accepted by the board on May 18, 2026. The same day, Mrs. Stela Choksi was appointed as the new CFO. Additionally, the board approved purchase of a 1 MG Windsor car for the company along with a loan facility from HDFC Bank, and initiated a process to change the Registrar and Share Transfer Agent from MUFG Intime India Private Limited to Ankit Consultancy Private Limited. The company clarified there was no delay in disclosing the CFO resignation as it was intimated on May 18, 2026.
The CFO change appears to be immediate within the same family (same surname), which may raise related party concerns for investors. The car purchase with bank financing and RTA change are routine administrative matters with minimal direct share price impact.